<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:sdc="http://www.alacra.com/sdc" xmlns:ccbn="http://www.alacra.com/ccbn" xmlns:newstex="http://www.alacra.com/newstex" ><channel><title>MDS Inc. RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>MDS Inc.</description>
<link>http://www.alacrastore.com/company-snapshot/MDS_Inc-1010249</link>
<lastBuildDate>Monday, September 08, 2008 1:11:24 PM</lastBuildDate>
<alacra:xlsid>1010249</alacra:xlsid>
<alacra:company>MDS Inc.</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><link>http://www.alacrastore.com/storecontent/ccbn/T1776848</link><guid isPermaLink="false">ccbn/T1776848</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good morning, ladies and gentlemen, welcome to the MDS third-quarter results conference call. I would like to turn the call over to Kim Lee, Director of investor relations. Please go ahead Ms. Lee. ...

</description><pubDate>9/4/2008 11:07:00 AM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">MDS Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">106.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">MDS Inc. Q3 2008 Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MDZ</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:30am ET</ccbn:time><title>MDS Inc. Q3 2008 Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1776848</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-27882056</link><guid isPermaLink="false">newstex/PRN-0005-27882056</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> Sep. #, #### (PR Newswire delivered by Newstex) -- Continuing to Take Action to Improve ProfitabilityTORONTO, Sept. # /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09015000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">01000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">01021000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016048</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016003</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04009000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04009002</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><pubDate>9/4/2008 8:23:47 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18008000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18010000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18020000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002012</newstex:geo><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>MDS Reports Third Quarter 2008 Financial Results</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-27882056</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MDS INC</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MDS</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MDZ</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0001-27882090</link><guid isPermaLink="false">newstex/PRN-0001-27882090</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> Sep. #, #### (Canada NewsWire Group delivered by Newstex) -- TORONTO, Sept. # /CNW/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today reported its third quarter...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09015000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">01000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">01021000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016048</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016003</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04009000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04009002</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002001</newstex:cat><pubDate>9/4/2008 8:23:46 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18008000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18010000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18020000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002012</newstex:geo><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">Canada NewsWire Group</newstex:Publication><title>MDS Reports Third Quarter 2008 Financial Results</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0001-27882090</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">LIFE SCIENCES RESEARCH INC</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MDS INC</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">LSR</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MDS</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MDZ</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-27506013</link><guid isPermaLink="false">newstex/PRN-0005-27506013</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> WASHINGTON, Aug. ##, #### (PRNewswire-USNewswire delivered by Newstex) -- The Association of Clinical Research Organizations (ACRO), which represents the clinical research organization (CRO) industry to regulators, biopharmaceutical...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09015000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016008</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13002005</newstex:cat><pubDate>8/19/2008 10:21:50 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18007000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Association of Clinical Research Organizations (ACRO) Welcomes Clinilabs and RPS as New Members</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-27506013</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MDS INC</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MDZ</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><title>MDS Inc buys back stock</title><description>CANADA - In June ####, the board of MDS Inc (MI), a provider of laboratory testing services, authorized the repurchase of up to #.### mil common shares, or about #.##% of the company's common stock outstanding, through a normal course issuer bid. Based on MI's closing stock price of ##.## Canadian dollars ($##.### US) on June ##, the last full trading day prior to the announcement of the board's approval, the buyback had an indicated value of C$##.### mil ($##.## mil) in cash.</description><pubDate>7/1/2008 11:39:58 AM</pubDate><sdc:company_cusip xmlns:sdc="http://www.alacra.com/sdc">55269P</sdc:company_cusip><sdc:target_company_cusip xmlns:sdc="http://www.alacra.com/sdc">55269P</sdc:target_company_cusip><sdc:company_cusip_up xmlns:sdc="http://www.alacra.com/sdc">55269P</sdc:company_cusip_up><sdc:target_company_cusip_up xmlns:sdc="http://www.alacra.com/sdc">55269P</sdc:target_company_cusip_up><sdc:company xmlns:sdc="http://www.alacra.com/sdc">MDS Inc</sdc:company><sdc:target_company xmlns:sdc="http://www.alacra.com/sdc">MDS Inc</sdc:target_company><sdc:company_up xmlns:sdc="http://www.alacra.com/sdc">MDS Inc</sdc:company_up><sdc:target_company_up xmlns:sdc="http://www.alacra.com/sdc">MDS Inc</sdc:target_company_up><link>http://www.alacrastore.com/storecontent/Thomson_M%26A/MDS_Inc_buys_back_stock-1992100040</link><guid isPermaLink="false">sdc/1992100040</guid><sdc:deal xmlns:sdc="http://www.alacra.com/sdc"><sdc:deal_no>1992100040</sdc:deal_no><sdc:_copyright><sdc:value>Copyright Â© 2008, Thomson Financial, All Rights Reserved</sdc:value></sdc:_copyright><sdc:a_EXCHANGE><sdc:value>Toronto</sdc:value></sdc:a_EXCHANGE><sdc:a_MAINDUSTRY><sdc:value>Health Services</sdc:value></sdc:a_MAINDUSTRY><sdc:a_NATION><sdc:value>Canada</sdc:value></sdc:a_NATION><sdc:a_SICDESC><sdc:value>Medical laboratories</sdc:value></sdc:a_SICDESC><sdc:a_SICPI><sdc:value>8071</sdc:value></sdc:a_SICPI><sdc:a_STATE><sdc:value>FF</sdc:value></sdc:a_STATE><sdc:a_STATELONG><sdc:value>Foreign</sdc:value></sdc:a_STATELONG><sdc:a_STATUS><sdc:value>Public</sdc:value></sdc:a_STATUS><sdc:a_TICKER><sdc:value>MDS</sdc:value></sdc:a_TICKER><sdc:asic_SIC><sdc:value sdc:p="0">3826:Laboratory analytical instruments</sdc:value><sdc:value sdc:p="1">3842:Orthopedic, prosthetic, and surgical supplies</sdc:value><sdc:value sdc:p="2">8071:Medical laboratories</sdc:value><sdc:value sdc:p="3">8082:Home health care services</sdc:value><sdc:value sdc:p="4">8734:Testing laboratories</sdc:value></sdc:asic_SIC><sdc:aupsic_SIC><sdc:value sdc:p="0">3826:Laboratory analytical instruments</sdc:value><sdc:value sdc:p="1">3842:Orthopedic, prosthetic, and surgical supplies</sdc:value><sdc:value sdc:p="2">8071:Medical laboratories</sdc:value><sdc:value sdc:p="3">8082:Home health care services</sdc:value><sdc:value sdc:p="4">8734:Testing laboratories</sdc:value></sdc:aupsic_SIC><sdc:b_EXCHANGE><sdc:value>Toronto</sdc:value></sdc:b_EXCHANGE><sdc:b_MAINDUSTRY><sdc:value>Health Services</sdc:value></sdc:b_MAINDUSTRY><sdc:b_NATION><sdc:value>Canada</sdc:value></sdc:b_NATION><sdc:b_SICDESC><sdc:value>Medical laboratories</sdc:value></sdc:b_SICDESC><sdc:b_SICPI><sdc:value>8071</sdc:value></sdc:b_SICPI><sdc:b_STATE><sdc:value>FF</sdc:value></sdc:b_STATE><sdc:b_STATELONG><sdc:value>Foreign</sdc:value></sdc:b_STATELONG><sdc:b_STATUS><sdc:value>Public</sdc:value></sdc:b_STATUS><sdc:b_TICKER><sdc:value>MDS</sdc:value></sdc:b_TICKER><sdc:c_ACIDGEN><sdc:value>103136002</sdc:value></sdc:c_ACIDGEN><sdc:c2up_BUSS><sdc:value>Pvd lab testing svcs</sdc:value></sdc:c2up_BUSS><sdc:c3up_BUSS><sdc:value>Pvd lab testing svcs</sdc:value></sdc:c3up_BUSS><sdc:co_DESCR><sdc:value sdc:p="0">Cash</sdc:value><sdc:value sdc:p="1">Cash Only</sdc:value></sdc:co_DESCR><sdc:cs_DESCR><sdc:value>Common Stock</sdc:value></sdc:cs_DESCR><sdc:d_TCIDGEN><sdc:value>103136002</sdc:value></sdc:d_TCIDGEN><sdc:date_lastupdate><sdc:value>Jul 1 2008</sdc:value></sdc:date_lastupdate><sdc:finbltm_BV><sdc:value>0.00000</sdc:value></sdc:finbltm_BV><sdc:finbltm_CASH><sdc:value>0.00000</sdc:value></sdc:finbltm_CASH><sdc:finbltm_CASHFLOW><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW><sdc:finbltm_CASHFLOW1><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW1><sdc:finbltm_CASHFLOW2><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW2><sdc:finbltm_CASHFLOW3><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW3><sdc:finbltm_CASHFLOW4><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW4><sdc:finbltm_CASHFLOW5><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW5><sdc:finbltm_COMEQ><sdc:value>0.00000</sdc:value></sdc:finbltm_COMEQ><sdc:finbltm_DEBTRAT><sdc:value>0.00000</sdc:value></sdc:finbltm_DEBTRAT><sdc:finbltm_DSER2><sdc:value>0.00000</sdc:value></sdc:finbltm_DSER2><sdc:finbltm_EBIT><sdc:value>0.00000</sdc:value></sdc:finbltm_EBIT><sdc:finbltm_EPS><sdc:value>0.00000</sdc:value></sdc:finbltm_EPS><sdc:finbltm_NI><sdc:value>0.00000</sdc:value></sdc:finbltm_NI><sdc:finbltm_PTINC><sdc:value>0.00000</sdc:value></sdc:finbltm_PTINC><sdc:finbltm_SALES><sdc:value>0.00000</sdc:value></sdc:finbltm_SALES><sdc:finbltm_STDEBT><sdc:value>0.00000</sdc:value></sdc:finbltm_STDEBT><sdc:finbltm_TASS><sdc:value>0.00000</sdc:value></sdc:finbltm_TASS><sdc:fiscal_ADCR><sdc:value>0.00000</sdc:value></sdc:fiscal_ADCR><sdc:fiscal_ANI><sdc:value>0.00000</sdc:value></sdc:fiscal_ANI><sdc:fiscal_APFDCR><sdc:value>0.00000</sdc:value></sdc:fiscal_APFDCR><sdc:fiscal_ASALES><sdc:value>0.00000</sdc:value></sdc:fiscal_ASALES><sdc:fiscal_ATASS><sdc:value>0.00000</sdc:value></sdc:fiscal_ATASS><sdc:fiscal_RATE><sdc:value>0.00000</sdc:value></sdc:fiscal_RATE><sdc:g_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value><sdc:value sdc:p="7">8.00000</sdc:value><sdc:value sdc:p="8">9.00000</sdc:value><sdc:value sdc:p="9">10.00000</sdc:value><sdc:value sdc:p="10">11.00000</sdc:value><sdc:value sdc:p="11">12.00000</sdc:value><sdc:value sdc:p="12">13.00000</sdc:value><sdc:value sdc:p="13">14.00000</sdc:value><sdc:value sdc:p="14">15.00000</sdc:value></sdc:g_SEQ><sdc:g_TEST><sdc:value sdc:p="0">MDS Inc, located in Toronto,</sdc:value><sdc:value sdc:p="1">Ontario, provides laboratory</sdc:value><sdc:value sdc:p="2">testing services, imaging</sdc:value><sdc:value sdc:p="3">agents for nuclear medicine</sdc:value><sdc:value sdc:p="4">testing, sterilization systems</sdc:value><sdc:value sdc:p="5">for medical and consumer</sdc:value><sdc:value sdc:p="6">products, research and</sdc:value><sdc:value sdc:p="7">clinical development services</sdc:value><sdc:value sdc:p="8">for planning and delivery of</sdc:value><sdc:value sdc:p="9">cancer treatment, and</sdc:value><sdc:value sdc:p="10">manufactures analytical</sdc:value><sdc:value sdc:p="11">instruments to assist in the</sdc:value><sdc:value sdc:p="12">development of new drugs, and</sdc:value><sdc:value sdc:p="13">medical/surgical supplies. The</sdc:value><sdc:value sdc:p="14">company was founded in 1969.</sdc:value></sdc:g_TEST><sdc:g_business><sdc:value sdc:p="0">MDS Inc, located in Toronto, Ontario, provides laboratory</sdc:value><sdc:value sdc:p="1">testing services, imaging agents for nuclear medicine</sdc:value><sdc:value sdc:p="2">testing, sterilization systems for medical and consumer</sdc:value><sdc:value sdc:p="3">products, research and clinical development services for</sdc:value><sdc:value sdc:p="4">planning and delivery of cancer treatment, and manufactures</sdc:value><sdc:value sdc:p="5">analytical instruments to assist in the development of new</sdc:value><sdc:value sdc:p="6">drugs, and medical/surgical supplies. The company was</sdc:value><sdc:value sdc:p="7">founded in 1969.</sdc:value></sdc:g_business><sdc:g_business1><sdc:value>MDS Inc, located in Toronto, Ontario, provides laboratory testing services, imaging agents for nuclear medicine testing, sterilization systems for medical and consumer products, research and clinical development services for planning and delivery of cancer treatment, and manufactures analytical instruments to assist in the development of new drugs, and medical/surgical supplies. The company was founded in 1969.</sdc:value></sdc:g_business1><sdc:h_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value><sdc:value sdc:p="7">8.00000</sdc:value><sdc:value sdc:p="8">9.00000</sdc:value><sdc:value sdc:p="9">10.00000</sdc:value><sdc:value sdc:p="10">11.00000</sdc:value><sdc:value sdc:p="11">12.00000</sdc:value><sdc:value sdc:p="12">13.00000</sdc:value><sdc:value sdc:p="13">14.00000</sdc:value><sdc:value sdc:p="14">15.00000</sdc:value></sdc:h_SEQ><sdc:h_TEST><sdc:value sdc:p="0">MDS Inc, located in Toronto,</sdc:value><sdc:value sdc:p="1">Ontario, provides laboratory</sdc:value><sdc:value sdc:p="2">testing services, imaging</sdc:value><sdc:value sdc:p="3">agents for nuclear medicine</sdc:value><sdc:value sdc:p="4">testing, sterilization systems</sdc:value><sdc:value sdc:p="5">for medical and consumer</sdc:value><sdc:value sdc:p="6">products, research and</sdc:value><sdc:value sdc:p="7">clinical development services</sdc:value><sdc:value sdc:p="8">for planning and delivery of</sdc:value><sdc:value sdc:p="9">cancer treatment, and</sdc:value><sdc:value sdc:p="10">manufactures analytical</sdc:value><sdc:value sdc:p="11">instruments to assist in the</sdc:value><sdc:value sdc:p="12">development of new drugs, and</sdc:value><sdc:value sdc:p="13">medical/surgical supplies. The</sdc:value><sdc:value sdc:p="14">company was founded in 1969.</sdc:value></sdc:h_TEST><sdc:h_business><sdc:value sdc:p="0">MDS Inc, located in Toronto, Ontario, provides laboratory</sdc:value><sdc:value sdc:p="1">testing services, imaging agents for nuclear medicine</sdc:value><sdc:value sdc:p="2">testing, sterilization systems for medical and consumer</sdc:value><sdc:value sdc:p="3">products, research and clinical development services for</sdc:value><sdc:value sdc:p="4">planning and delivery of cancer treatment, and manufactures</sdc:value><sdc:value sdc:p="5">analytical instruments to assist in the development of new</sdc:value><sdc:value sdc:p="6">drugs, and medical/surgical supplies. The company was</sdc:value><sdc:value sdc:p="7">founded in 1969.</sdc:value></sdc:h_business><sdc:h_business1><sdc:value>MDS Inc, located in Toronto, Ontario, provides laboratory testing services, imaging agents for nuclear medicine testing, sterilization systems for medical and consumer products, research and clinical development services for planning and delivery of cancer treatment, and manufactures analytical instruments to assist in the development of new drugs, and medical/surgical supplies. The company was founded in 1969.</sdc:value></sdc:h_business1><sdc:i_AFEEPCT><sdc:value>0.00000</sdc:value></sdc:i_AFEEPCT><sdc:i_AFEETOT><sdc:value>0.00000</sdc:value></sdc:i_AFEETOT><sdc:i_ATERMFEE><sdc:value>0.00000</sdc:value></sdc:i_ATERMFEE><sdc:i_COMOUT><sdc:value>122.03000</sdc:value></sdc:i_COMOUT><sdc:i_CROSS1><sdc:value>N</sdc:value></sdc:i_CROSS1><sdc:i_CURRENCYLONG><sdc:value>Canadian Dollar</sdc:value></sdc:i_CURRENCYLONG><sdc:i_DATEANN><sdc:value>30 Jun 08</sdc:value></sdc:i_DATEANN><sdc:i_DATEANN2><sdc:value>Mon, 30 Jun 2008 00:00:00 EST</sdc:value></sdc:i_DATEANN2><sdc:i_DATEANNS><sdc:value>Date Announced: 06/30/2008</sdc:value></sdc:i_DATEANNS><sdc:i_DATEEFFS><sdc:value>Date Effective:</sdc:value></sdc:i_DATEEFFS><sdc:i_DESCR><sdc:value>Buyback</sdc:value></sdc:i_DESCR><sdc:i_DESCR1><sdc:value>Not Appl.</sdc:value></sdc:i_DESCR1><sdc:i_FEEPCT><sdc:value>0.00000</sdc:value></sdc:i_FEEPCT><sdc:i_FEETOT><sdc:value>0.00000</sdc:value></sdc:i_FEETOT><sdc:i_HOSTAFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTAFEETOT><sdc:i_HOSTENTVAL><sdc:value>0.00000</sdc:value></sdc:i_HOSTENTVAL><sdc:i_HOSTFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTFEETOT><sdc:i_HOSTPR><sdc:value>16.24000</sdc:value></sdc:i_HOSTPR><sdc:i_HOSTPRLABEL><sdc:value>Price/Share</sdc:value></sdc:i_HOSTPRLABEL><sdc:i_HOSTTFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTTFEETOT><sdc:i_HOSTVALUE><sdc:value>67.181 Canadian Dollar</sdc:value></sdc:i_HOSTVALUE><sdc:i_HOSTVALUE1><sdc:value>67.18100</sdc:value></sdc:i_HOSTVALUE1><sdc:i_HOST_EQVAL><sdc:value>1981.74000</sdc:value></sdc:i_HOST_EQVAL><sdc:i_HOST_RANKVAL><sdc:value>67.181 Canadian Dollar</sdc:value></sdc:i_HOST_RANKVAL><sdc:i_HOST_RANKVAL1><sdc:value>67.18100</sdc:value></sdc:i_HOST_RANKVAL1><sdc:i_PCTACQ><sdc:value>0.00000</sdc:value></sdc:i_PCTACQ><sdc:i_PCTOWN><sdc:value>0.00000</sdc:value></sdc:i_PCTOWN><sdc:i_PR><sdc:value>16.07300</sdc:value></sdc:i_PR><sdc:i_PR_INITIAL><sdc:value>16.07300</sdc:value></sdc:i_PR_INITIAL><sdc:i_RANKVAL><sdc:value>67.18100</sdc:value></sdc:i_RANKVAL><sdc:i_RANK_HOSTRANKVAL><sdc:value>67.181 Canadian Dollar</sdc:value></sdc:i_RANK_HOSTRANKVAL><sdc:i_RATE><sdc:value>0.99000</sdc:value></sdc:i_RATE><sdc:i_STATUS_MMC><sdc:value>N</sdc:value></sdc:i_STATUS_MMC><sdc:i_STGVAL><sdc:value>33.33600</sdc:value></sdc:i_STGVAL><sdc:i_TERMFEE><sdc:value>0.00000</sdc:value></sdc:i_TERMFEE><sdc:i_TFEEPCT><sdc:value>0.00000</sdc:value></sdc:i_TFEEPCT><sdc:i_TFEETOT><sdc:value>0.00000</sdc:value></sdc:i_TFEETOT><sdc:i_TTERMFEE><sdc:value>0.00000</sdc:value></sdc:i_TTERMFEE><sdc:i_VALLIA><sdc:value>0.00000</sdc:value></sdc:i_VALLIA><sdc:i_VALNOLIA><sdc:value>66.49000</sdc:value></sdc:i_VALNOLIA><sdc:i_VALUE><sdc:value>66.49000</sdc:value></sdc:i_VALUE><sdc:j_EQVALCF><sdc:value>0.00000</sdc:value></sdc:j_EQVALCF><sdc:j_EVCF><sdc:value>0.00000</sdc:value></sdc:j_EVCF><sdc:j_EVEBIT><sdc:value>0.00000</sdc:value></sdc:j_EVEBIT><sdc:j_EVNI><sdc:value>0.00000</sdc:value></sdc:j_EVNI><sdc:j_EVSALES><sdc:value>0.00000</sdc:value></sdc:j_EVSALES><sdc:j_MPRICEBOOK><sdc:value>0.00000</sdc:value></sdc:j_MPRICEBOOK><sdc:j_PHELD><sdc:value>0.00000</sdc:value></sdc:j_PHELD><sdc:j_PSOUGHT><sdc:value>3.39000</sdc:value></sdc:j_PSOUGHT><sdc:j_RANKVALCF><sdc:value>0.00000</sdc:value></sdc:j_RANKVALCF><sdc:j_RANKVALEB><sdc:value>0.00000</sdc:value></sdc:j_RANKVALEB><sdc:j_RANKVALNA><sdc:value>0.00000</sdc:value></sdc:j_RANKVALNA><sdc:j_RANKVALNI><sdc:value>0.00000</sdc:value></sdc:j_RANKVALNI><sdc:j_RANKVALSALES><sdc:value>0.00000</sdc:value></sdc:j_RANKVALSALES><sdc:j_VALEB><sdc:value>0.00000</sdc:value></sdc:j_VALEB><sdc:j_VALNI><sdc:value>0.00000</sdc:value></sdc:j_VALNI><sdc:j_VALSALES><sdc:value>0.00000</sdc:value></sdc:j_VALSALES><sdc:m_AMV><sdc:value>0.00000</sdc:value></sdc:m_AMV><sdc:m_CF3YGR><sdc:value>0.00000</sdc:value></sdc:m_CF3YGR><sdc:m_CF5YGR><sdc:value>0.00000</sdc:value></sdc:m_CF5YGR><sdc:m_DCR><sdc:value>0.00000</sdc:value></sdc:m_DCR><sdc:m_ENTVAL><sdc:value>0.00000</sdc:value></sdc:m_ENTVAL><sdc:m_EPS3YGR><sdc:value>0.00000</sdc:value></sdc:m_EPS3YGR><sdc:m_EPS5YGR><sdc:value>0.00000</sdc:value></sdc:m_EPS5YGR><sdc:m_LTD><sdc:value>0.00000</sdc:value></sdc:m_LTD><sdc:m_MV><sdc:value>0.00000</sdc:value></sdc:m_MV><sdc:m_NETASS><sdc:value>0.00000</sdc:value></sdc:m_NETASS><sdc:m_NETASS3YGR><sdc:value>0.00000</sdc:value></sdc:m_NETASS3YGR><sdc:m_NETASS5YGR><sdc:value>0.00000</sdc:value></sdc:m_NETASS5YGR><sdc:m_NI3YGR><sdc:value>0.00000</sdc:value></sdc:m_NI3YGR><sdc:m_NI5YGR><sdc:value>0.00000</sdc:value></sdc:m_NI5YGR><sdc:n_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value><sdc:value sdc:p="7">8.00000</sdc:value><sdc:value sdc:p="8">9.00000</sdc:value><sdc:value sdc:p="9">10.00000</sdc:value><sdc:value sdc:p="10">11.00000</sdc:value><sdc:value sdc:p="11">12.00000</sdc:value><sdc:value sdc:p="12">13.00000</sdc:value><sdc:value sdc:p="13">14.00000</sdc:value><sdc:value sdc:p="14">15.00000</sdc:value><sdc:value sdc:p="15">16.00000</sdc:value><sdc:value sdc:p="16">17.00000</sdc:value><sdc:value sdc:p="17">18.00000</sdc:value></sdc:n_SEQ><sdc:n_SYNOPSIS><sdc:value sdc:p="0">CANADA - In June 2008, the</sdc:value><sdc:value sdc:p="1">board of MDS Inc (MI), a</sdc:value><sdc:value sdc:p="2">provider of laboratory testing</sdc:value><sdc:value sdc:p="3">services, authorized the</sdc:value><sdc:value sdc:p="4">repurchase of up to 4.137 mil</sdc:value><sdc:value sdc:p="5">common shares, or about 3.39%</sdc:value><sdc:value sdc:p="6">of the company's common stock</sdc:value><sdc:value sdc:p="7">outstanding, through a normal</sdc:value><sdc:value sdc:p="8">course issuer bid. Based on</sdc:value><sdc:value sdc:p="9">MI's closing stock price of</sdc:value><sdc:value sdc:p="10">16.24 Canadian dollars</sdc:value><sdc:value sdc:p="11">($16.073 US) on June 27, the</sdc:value><sdc:value sdc:p="12">last full trading day prior to</sdc:value><sdc:value sdc:p="13">the announcement of the</sdc:value><sdc:value sdc:p="14">board's approval, the buyback</sdc:value><sdc:value sdc:p="15">had an indicated value of</sdc:value><sdc:value sdc:p="16">C$67.181 mil ($66.49 mil) in</sdc:value><sdc:value sdc:p="17">cash.</sdc:value></sdc:n_SYNOPSIS><sdc:n_synopsis2><sdc:value>CANADA - In June 2008, the board of MDS Inc (MI), a provider of laboratory testing services, authorized the repurchase of up to 4.137 mil common shares, or about 3.39% of the company's common stock outstanding, through a normal course issuer bid. Based on MI's closing stock price of 16.24 Canadian dollars ($16.073 US) on June 27, the last full trading day prior to the announcement of the board's approval, the buyback had an indicated value of C$67.181 mil ($66.49 mil) in cash.</sdc:value></sdc:n_synopsis2><sdc:n_synopsis3><sdc:value sdc:p="0">CANADA - In June 2008, the board of MDS Inc (MI), a provider of laboratory testing</sdc:value><sdc:value sdc:p="1">services, authorized the repurchase of up to 4.137 mil common shares, or about 3.39% of</sdc:value><sdc:value sdc:p="2">the company's common stock outstanding, through a normal course issuer bid. Based on MI's</sdc:value><sdc:value sdc:p="3">closing stock price of 16.24 Canadian dollars ($16.073 US) on June 27, the last full</sdc:value><sdc:value sdc:p="4">trading day prior to the announcement of the board's approval, the buyback had an</sdc:value><sdc:value sdc:p="5">indicated value of C$67.181 mil ($66.49 mil) in cash.</sdc:value></sdc:n_synopsis3><sdc:n_synopsis4><sdc:value sdc:p="0">CANADA - In June 2008, the board of MDS Inc (MI), a provider of laboratory testing services, authorized the repurchase of up to 4.137 mil common shares, or about 3.39% of the company's common stock</sdc:value><sdc:value sdc:p="1">outstanding, through a normal course issuer bid. Based on MI's closing stock price of 16.24 Canadian dollars ($16.073 US) on June 27, the last full trading day prior to the announcement of the board's</sdc:value><sdc:value sdc:p="2">approval, the buyback had an indicated value of C$67.181 mil ($66.49 mil) in cash.</sdc:value></sdc:n_synopsis4><sdc:n_synopsis5><sdc:value sdc:p="0">CANADA - In June 2008, the board of MDS Inc (MI), a provider of laboratory testing services, authorized the repurchase of up to 4.137 mil</sdc:value><sdc:value sdc:p="1">common shares, or about 3.39% of the company's common stock outstanding, through a normal course issuer bid. Based on MI's closing stock</sdc:value><sdc:value sdc:p="2">price of 16.24 Canadian dollars ($16.073 US) on June 27, the last full trading day prior to the announcement of the board's approval, the</sdc:value><sdc:value sdc:p="3">buyback had an indicated value of C$67.181 mil ($66.49 mil) in cash.</sdc:value></sdc:n_synopsis5><sdc:q_DESCR><sdc:value>Intended</sdc:value></sdc:q_DESCR><sdc:q_HOSTANETASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTANETASS><sdc:q_HOSTANILTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTANILTM><sdc:q_HOSTASALESLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTASALESLTM><sdc:q_HOSTATASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTATASS><sdc:q_HOSTBOOKVALUE><sdc:value>0.00000</sdc:value></sdc:q_HOSTBOOKVALUE><sdc:q_HOSTCASHFLOW><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW><sdc:q_HOSTCASHFLOW1><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW1><sdc:q_HOSTCASHFLOW2><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW2><sdc:q_HOSTCASHFLOW3><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW3><sdc:q_HOSTCASHFLOW4><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW4><sdc:q_HOSTCASHFLOW5><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW5><sdc:q_HOSTCOMMONEQUITY><sdc:value>0.00000</sdc:value></sdc:q_HOSTCOMMONEQUITY><sdc:q_HOSTEBITLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTEBITLTM><sdc:q_HOSTEPS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS1><sdc:q_HOSTEPS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS2><sdc:q_HOSTEPS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS3><sdc:q_HOSTEPS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS4><sdc:q_HOSTEPS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS5><sdc:q_HOSTEPSLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPSLTM><sdc:q_HOSTNETASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS><sdc:q_HOSTNETASS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS1><sdc:q_HOSTNETASS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS2><sdc:q_HOSTNETASS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS3><sdc:q_HOSTNETASS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS4><sdc:q_HOSTNETASS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS5><sdc:q_HOSTNI1><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI1><sdc:q_HOSTNI2><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI2><sdc:q_HOSTNI3><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI3><sdc:q_HOSTNI4><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI4><sdc:q_HOSTNI5><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI5><sdc:q_HOSTNILTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTNILTM><sdc:q_HOSTPTINC1><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC1><sdc:q_HOSTPTINC2><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC2><sdc:q_HOSTPTINC3><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC3><sdc:q_HOSTPTINC4><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC4><sdc:q_HOSTPTINC5><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC5><sdc:q_HOSTPTINCLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINCLTM><sdc:q_HOSTSALES1><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES1><sdc:q_HOSTSALES2><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES2><sdc:q_HOSTSALES3><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES3><sdc:q_HOSTSALES4><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES4><sdc:q_HOSTSALES5><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES5><sdc:q_HOSTSALESLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALESLTM><sdc:q_HOSTTASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS><sdc:q_HOSTTASS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS1><sdc:q_HOSTTASS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS2><sdc:q_HOSTTASS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS3><sdc:q_HOSTTASS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS4><sdc:q_HOSTTASS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS5><sdc:q_STATUS><sdc:value>Status:Intended</sdc:value></sdc:q_STATUS><sdc:r_PE><sdc:value>-999.00000</sdc:value></sdc:r_PE><sdc:r_PE_PRINT><sdc:value>np</sdc:value></sdc:r_PE_PRINT><sdc:r_PFTMARG><sdc:value>0.00000</sdc:value></sdc:r_PFTMARG><sdc:r_PRICEBOOK><sdc:value>-999.00000</sdc:value></sdc:r_PRICEBOOK><sdc:r_PRICEBOOK_PRINT><sdc:value>np</sdc:value></sdc:r_PRICEBOOK_PRINT><sdc:r_PTINC3YGR><sdc:value>0.00000</sdc:value></sdc:r_PTINC3YGR><sdc:r_PTINC5YGR><sdc:value>0.00000</sdc:value></sdc:r_PTINC5YGR><sdc:r_ROE><sdc:value>0.00000</sdc:value></sdc:r_ROE><sdc:r_SALES3YGR><sdc:value>0.00000</sdc:value></sdc:r_SALES3YGR><sdc:r_SALES5YGR><sdc:value>0.00000</sdc:value></sdc:r_SALES5YGR><sdc:r_SE><sdc:value>0.00000</sdc:value></sdc:r_SE><sdc:r_TASS3YGR><sdc:value>0.00000</sdc:value></sdc:r_TASS3YGR><sdc:r_TASS5YGR><sdc:value>0.00000</sdc:value></sdc:r_TASS5YGR><sdc:r_TTCFMULT><sdc:value>0.00000</sdc:value></sdc:r_TTCFMULT><sdc:r_TTEBITMULT><sdc:value>0.00000</sdc:value></sdc:r_TTEBITMULT><sdc:r_VALNA><sdc:value>0.00000</sdc:value></sdc:r_VALNA><sdc:sic_SIC><sdc:value sdc:p="0">3826:Laboratory analytical instruments</sdc:value><sdc:value sdc:p="1">3842:Orthopedic, prosthetic, and surgical supplies</sdc:value><sdc:value sdc:p="2">8071:Medical laboratories</sdc:value><sdc:value sdc:p="3">8082:Home health care services</sdc:value><sdc:value sdc:p="4">8734:Testing laboratories</sdc:value></sdc:sic_SIC><sdc:upa_UPACIDGEN><sdc:value>103136002</sdc:value></sdc:upa_UPACIDGEN><sdc:upa1_EXCHANGE><sdc:value>Toronto</sdc:value></sdc:upa1_EXCHANGE><sdc:upa1_NATION><sdc:value>Canada</sdc:value></sdc:upa1_NATION><sdc:upa1_SICP><sdc:value>8071</sdc:value></sdc:upa1_SICP><sdc:upa1_STATE><sdc:value>Foreign</sdc:value></sdc:upa1_STATE><sdc:upa1_STATUS><sdc:value>Public</sdc:value></sdc:upa1_STATUS><sdc:upa1_TICKER><sdc:value>MDS</sdc:value></sdc:upa1_TICKER><sdc:upsic_SIC><sdc:value sdc:p="0">3826:Laboratory analytical instruments</sdc:value><sdc:value sdc:p="1">3842:Orthopedic, prosthetic, and surgical supplies</sdc:value><sdc:value sdc:p="2">8071:Medical laboratories</sdc:value><sdc:value sdc:p="3">8082:Home health care services</sdc:value><sdc:value sdc:p="4">8734:Testing laboratories</sdc:value></sdc:upsic_SIC><sdc:upt_UPTCIDGEN><sdc:value>103136002</sdc:value></sdc:upt_UPTCIDGEN><sdc:upt1_EXCHANGE><sdc:value>Toronto</sdc:value></sdc:upt1_EXCHANGE><sdc:upt1_NATION><sdc:value>Canada</sdc:value></sdc:upt1_NATION><sdc:upt1_SICP><sdc:value>8071</sdc:value></sdc:upt1_SICP><sdc:upt1_STATE><sdc:value>Foreign</sdc:value></sdc:upt1_STATE><sdc:upt1_STATUS><sdc:value>Public</sdc:value></sdc:upt1_STATUS><sdc:upt1_TICKER><sdc:value>MDS</sdc:value></sdc:upt1_TICKER><sdc:x_RANK1_VALUE><sdc:value>66.49000</sdc:value></sdc:x_RANK1_VALUE><sdc:x_RANK_HOSTRANKVAL><sdc:value>67.18100</sdc:value></sdc:x_RANK_HOSTRANKVAL><sdc:x_RANK_RANKVAL><sdc:value>66.49000</sdc:value></sdc:x_RANK_RANKVAL><sdc:x_rank_rankstgval><sdc:value>33.33600</sdc:value></sdc:x_rank_rankstgval></sdc:deal><category>Deal Information</category><alacra:ip>Thomson Financial Mergers &amp; Acquisitions</alacra:ip></item><item><title>MDS Analytical Technologies acquires Blueshift Biotechnologies Inc</title><description>US - MDS Analytical Technologies, a unit of MDS Inc, acquired Blueshift Biotechnologies Inc, a manufacturer of semiconductor inspection instruments, for $## mil.</description><pubDate>6/28/2008 9:21:39 AM</pubDate><sdc:company_cusip xmlns:sdc="http://www.alacra.com/sdc">55651Q</sdc:company_cusip><sdc:target_company_cusip xmlns:sdc="http://www.alacra.com/sdc">09620N</sdc:target_company_cusip><sdc:company_cusip_up xmlns:sdc="http://www.alacra.com/sdc">55269P</sdc:company_cusip_up><sdc:target_company_cusip_up xmlns:sdc="http://www.alacra.com/sdc">09620N</sdc:target_company_cusip_up><sdc:company xmlns:sdc="http://www.alacra.com/sdc">MDS Analytical Technologies</sdc:company><sdc:target_company xmlns:sdc="http://www.alacra.com/sdc">Blueshift Biotechnologies Inc</sdc:target_company><sdc:company_up xmlns:sdc="http://www.alacra.com/sdc">MDS Inc</sdc:company_up><sdc:target_company_up xmlns:sdc="http://www.alacra.com/sdc">Blueshift Biotechnologies Inc</sdc:target_company_up><link>http://www.alacrastore.com/storecontent/Thomson_M%26A/MDS_Analytical_Technologies_acquires_Blueshift_Biotechnologies_Inc-1991237020</link><guid isPermaLink="false">sdc/1991237020</guid><sdc:deal xmlns:sdc="http://www.alacra.com/sdc"><sdc:deal_no>1991237020</sdc:deal_no><sdc:_copyright><sdc:value>Copyright Â© 2008, Thomson Financial, All Rights Reserved</sdc:value></sdc:_copyright><sdc:a_MAINDUSTRY><sdc:value>Measuring, Medical, Photo Equipment; Clocks</sdc:value></sdc:a_MAINDUSTRY><sdc:a_NATION><sdc:value>United States</sdc:value></sdc:a_NATION><sdc:a_SICDESC><sdc:value>Laboratory analytical instruments</sdc:value></sdc:a_SICDESC><sdc:a_SICPI><sdc:value>3826</sdc:value></sdc:a_SICPI><sdc:a_STATE><sdc:value>CA</sdc:value></sdc:a_STATE><sdc:a_STATELONG><sdc:value>California</sdc:value></sdc:a_STATELONG><sdc:a_STATUS><sdc:value>Subsidiary</sdc:value></sdc:a_STATUS><sdc:asic_SIC><sdc:value sdc:p="0">3823:Process control instruments</sdc:value><sdc:value sdc:p="1">3826:Laboratory analytical instruments</sdc:value><sdc:value sdc:p="2">3829:Measuring&amp;controlling devices</sdc:value><sdc:value sdc:p="3">3845:Electromedical and electrotherapeutic apparatus</sdc:value><sdc:value sdc:p="4">8731:Commercial physical and biological research</sdc:value></sdc:asic_SIC><sdc:aupsic_SIC><sdc:value sdc:p="0">3826:Laboratory analytical instruments</sdc:value><sdc:value sdc:p="1">3842:Orthopedic, prosthetic, and surgical supplies</sdc:value><sdc:value sdc:p="2">8071:Medical laboratories</sdc:value><sdc:value sdc:p="3">8082:Home health care services</sdc:value><sdc:value sdc:p="4">8734:Testing laboratories</sdc:value></sdc:aupsic_SIC><sdc:b_MAINDUSTRY><sdc:value>Measuring, Medical, Photo Equipment; Clocks</sdc:value></sdc:b_MAINDUSTRY><sdc:b_NATION><sdc:value>United States</sdc:value></sdc:b_NATION><sdc:b_SICDESC><sdc:value>Laboratory analytical instruments</sdc:value></sdc:b_SICDESC><sdc:b_SICPI><sdc:value>3826</sdc:value></sdc:b_SICPI><sdc:b_STATE><sdc:value>CA</sdc:value></sdc:b_STATE><sdc:b_STATELONG><sdc:value>California</sdc:value></sdc:b_STATELONG><sdc:b_STATUS><sdc:value>Private</sdc:value></sdc:b_STATUS><sdc:c_ACIDGEN><sdc:value>1025593001</sdc:value></sdc:c_ACIDGEN><sdc:c2up_BUSS><sdc:value>Pvd lab testing svcs</sdc:value></sdc:c2up_BUSS><sdc:c3up_BUSS><sdc:value>Mnfr inspection instr</sdc:value></sdc:c3up_BUSS><sdc:co_DESCR><sdc:value sdc:p="0">Cash</sdc:value><sdc:value sdc:p="1">Cash Only</sdc:value></sdc:co_DESCR><sdc:cs_DESCR><sdc:value>Assets</sdc:value></sdc:cs_DESCR><sdc:d_TCIDGEN><sdc:value>1025595001</sdc:value></sdc:d_TCIDGEN><sdc:date_lastupdate><sdc:value>Jun 28 2008</sdc:value></sdc:date_lastupdate><sdc:finbltm_BV><sdc:value>0.00000</sdc:value></sdc:finbltm_BV><sdc:finbltm_CASH><sdc:value>0.00000</sdc:value></sdc:finbltm_CASH><sdc:finbltm_CASHFLOW><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW><sdc:finbltm_CASHFLOW1><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW1><sdc:finbltm_CASHFLOW2><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW2><sdc:finbltm_CASHFLOW3><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW3><sdc:finbltm_CASHFLOW4><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW4><sdc:finbltm_CASHFLOW5><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW5><sdc:finbltm_COMEQ><sdc:value>0.00000</sdc:value></sdc:finbltm_COMEQ><sdc:finbltm_DEBTRAT><sdc:value>0.00000</sdc:value></sdc:finbltm_DEBTRAT><sdc:finbltm_DSER2><sdc:value>0.00000</sdc:value></sdc:finbltm_DSER2><sdc:finbltm_EBIT><sdc:value>0.00000</sdc:value></sdc:finbltm_EBIT><sdc:finbltm_EPS><sdc:value>0.00000</sdc:value></sdc:finbltm_EPS><sdc:finbltm_NI><sdc:value>0.00000</sdc:value></sdc:finbltm_NI><sdc:finbltm_PTINC><sdc:value>0.00000</sdc:value></sdc:finbltm_PTINC><sdc:finbltm_SALES><sdc:value>0.75000</sdc:value></sdc:finbltm_SALES><sdc:finbltm_STDEBT><sdc:value>0.00000</sdc:value></sdc:finbltm_STDEBT><sdc:finbltm_TASS><sdc:value>0.00000</sdc:value></sdc:finbltm_TASS><sdc:fiscal_ADCR><sdc:value>0.00000</sdc:value></sdc:fiscal_ADCR><sdc:fiscal_AEPS><sdc:value>0.00000</sdc:value></sdc:fiscal_AEPS><sdc:fiscal_ANI><sdc:value>0.00000</sdc:value></sdc:fiscal_ANI><sdc:fiscal_APFDCR><sdc:value>0.00000</sdc:value></sdc:fiscal_APFDCR><sdc:fiscal_ASALES><sdc:value>0.00000</sdc:value></sdc:fiscal_ASALES><sdc:fiscal_ATASS><sdc:value>0.00000</sdc:value></sdc:fiscal_ATASS><sdc:fiscal_DATEFIN><sdc:value>31 Dec 07</sdc:value></sdc:fiscal_DATEFIN><sdc:fiscal_FISCAL><sdc:value>31 Dec 07</sdc:value></sdc:fiscal_FISCAL><sdc:fiscal_FISCAL1><sdc:value>31 Dec 06</sdc:value></sdc:fiscal_FISCAL1><sdc:fiscal_FISCAL2><sdc:value>31 Dec 05</sdc:value></sdc:fiscal_FISCAL2><sdc:fiscal_FISCAL3><sdc:value>31 Dec 04</sdc:value></sdc:fiscal_FISCAL3><sdc:fiscal_FISCAL4><sdc:value>31 Dec 03</sdc:value></sdc:fiscal_FISCAL4><sdc:fiscal_RATE><sdc:value>1.00000</sdc:value></sdc:fiscal_RATE><sdc:g_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value><sdc:value sdc:p="7">8.00000</sdc:value><sdc:value sdc:p="8">9.00000</sdc:value><sdc:value sdc:p="9">10.00000</sdc:value><sdc:value sdc:p="10">11.00000</sdc:value><sdc:value sdc:p="11">12.00000</sdc:value><sdc:value sdc:p="12">13.00000</sdc:value><sdc:value sdc:p="13">14.00000</sdc:value><sdc:value sdc:p="14">15.00000</sdc:value></sdc:g_SEQ><sdc:g_TEST><sdc:value sdc:p="0">MDS Analytical Technologies,</sdc:value><sdc:value sdc:p="1">located in Union City,</sdc:value><sdc:value sdc:p="2">California, manufactures</sdc:value><sdc:value sdc:p="3">analytical instruments,</sdc:value><sdc:value sdc:p="4">including cell and plate</sdc:value><sdc:value sdc:p="5">washers and dispensers,</sdc:value><sdc:value sdc:p="6">bioanalytical measurement</sdc:value><sdc:value sdc:p="7">systems, cell harvesters,</sdc:value><sdc:value sdc:p="8">supernatant collection system</sdc:value><sdc:value sdc:p="9">for drug discovery and life</sdc:value><sdc:value sdc:p="10">science research. The</sdc:value><sdc:value sdc:p="11">company's life sciences tools</sdc:value><sdc:value sdc:p="12">comprised of two channel</sdc:value><sdc:value sdc:p="13">brands, Sciex and Molecular</sdc:value><sdc:value sdc:p="14">Devices.</sdc:value></sdc:g_TEST><sdc:g_business><sdc:value sdc:p="0">MDS Analytical Technologies, located in Union City,</sdc:value><sdc:value sdc:p="1">California, manufactures analytical instruments, including</sdc:value><sdc:value sdc:p="2">cell and plate washers and dispensers, bioanalytical</sdc:value><sdc:value sdc:p="3">measurement systems, cell harvesters, supernatant collection</sdc:value><sdc:value sdc:p="4">system for drug discovery and life science research. The</sdc:value><sdc:value sdc:p="5">company's life sciences tools comprised of two channel</sdc:value><sdc:value sdc:p="6">brands, Sciex and Molecular Devices.</sdc:value></sdc:g_business><sdc:g_business1><sdc:value>MDS Analytical Technologies, located in Union City, California, manufactures analytical instruments, including cell and plate washers and dispensers, bioanalytical measurement systems, cell harvesters, supernatant collection system for drug discovery and life science research. The company's life sciences tools comprised of two channel brands, Sciex and Molecular Devices.</sdc:value></sdc:g_business1><sdc:h_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value><sdc:value sdc:p="7">8.00000</sdc:value><sdc:value sdc:p="8">9.00000</sdc:value><sdc:value sdc:p="9">10.00000</sdc:value></sdc:h_SEQ><sdc:h_TEST><sdc:value sdc:p="0">Blueshift Biotechnologies Inc,</sdc:value><sdc:value sdc:p="1">located in Sunnyvale,</sdc:value><sdc:value sdc:p="2">California, manufactures</sdc:value><sdc:value sdc:p="3">semiconductor inspection</sdc:value><sdc:value sdc:p="4">instruments for life sciences</sdc:value><sdc:value sdc:p="5">research. The company also</sdc:value><sdc:value sdc:p="6">develops screening platform</sdc:value><sdc:value sdc:p="7">and manufactures IsoCyte (TM</sdc:value><sdc:value sdc:p="8">benchtop laser scanning</sdc:value><sdc:value sdc:p="9">cytometer.</sdc:value></sdc:h_TEST><sdc:h_business><sdc:value sdc:p="0">Blueshift Biotechnologies Inc, located in Sunnyvale,</sdc:value><sdc:value sdc:p="1">California, manufactures semiconductor inspection</sdc:value><sdc:value sdc:p="2">instruments for life sciences research. The company also</sdc:value><sdc:value sdc:p="3">develops screening platform and manufactures IsoCyte (TM</sdc:value><sdc:value sdc:p="4">benchtop laser scanning cytometer.</sdc:value></sdc:h_business><sdc:h_business1><sdc:value>Blueshift Biotechnologies Inc, located in Sunnyvale, California, manufactures semiconductor inspection instruments for life sciences research. The company also develops screening platform and manufactures IsoCyte (TM benchtop laser scanning cytometer.</sdc:value></sdc:h_business1><sdc:i_AFEEPCT><sdc:value>0.00000</sdc:value></sdc:i_AFEEPCT><sdc:i_AFEETOT><sdc:value>0.00000</sdc:value></sdc:i_AFEETOT><sdc:i_ATERMFEE><sdc:value>0.00000</sdc:value></sdc:i_ATERMFEE><sdc:i_COMOUT><sdc:value>0.00000</sdc:value></sdc:i_COMOUT><sdc:i_CROSS1><sdc:value>Y</sdc:value></sdc:i_CROSS1><sdc:i_CURRENCYLONG><sdc:value>U.S. Dollar</sdc:value></sdc:i_CURRENCYLONG><sdc:i_DATEANN><sdc:value>27 Jun 08</sdc:value></sdc:i_DATEANN><sdc:i_DATEANN2><sdc:value>Fri, 27 Jun 2008 00:00:00 EST</sdc:value></sdc:i_DATEANN2><sdc:i_DATEANNS><sdc:value>Date Announced: 06/27/2008</sdc:value></sdc:i_DATEANNS><sdc:i_DATEEFF><sdc:value>27 Jun 08</sdc:value></sdc:i_DATEEFF><sdc:i_DATEEFFS><sdc:value>Date Effective: 06/27/2008</sdc:value></sdc:i_DATEEFFS><sdc:i_DATEUNCON><sdc:value>27 Jun 08</sdc:value></sdc:i_DATEUNCON><sdc:i_DESCR><sdc:value>Acq. of Assets</sdc:value></sdc:i_DESCR><sdc:i_DESCR1><sdc:value>Friendly</sdc:value></sdc:i_DESCR1><sdc:i_FEEPCT><sdc:value>0.00000</sdc:value></sdc:i_FEEPCT><sdc:i_FEETOT><sdc:value>0.00000</sdc:value></sdc:i_FEETOT><sdc:i_HOSTAFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTAFEETOT><sdc:i_HOSTENTVAL><sdc:value>0.00000</sdc:value></sdc:i_HOSTENTVAL><sdc:i_HOSTFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTFEETOT><sdc:i_HOSTPR><sdc:value>0.00000</sdc:value></sdc:i_HOSTPR><sdc:i_HOSTPRLABEL><sdc:value>Price/Share</sdc:value></sdc:i_HOSTPRLABEL><sdc:i_HOSTTFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTTFEETOT><sdc:i_HOSTVALUE><sdc:value>13 U.S. Dollar</sdc:value></sdc:i_HOSTVALUE><sdc:i_HOSTVALUE1><sdc:value>13.00000</sdc:value></sdc:i_HOSTVALUE1><sdc:i_HOST_EQVAL><sdc:value>0.00000</sdc:value></sdc:i_HOST_EQVAL><sdc:i_HOST_RANKVAL><sdc:value>13 U.S. Dollar</sdc:value></sdc:i_HOST_RANKVAL><sdc:i_HOST_RANKVAL1><sdc:value>13.00000</sdc:value></sdc:i_HOST_RANKVAL1><sdc:i_PCTACQ><sdc:value>100.00000</sdc:value></sdc:i_PCTACQ><sdc:i_PCTOWN><sdc:value>100.00000</sdc:value></sdc:i_PCTOWN><sdc:i_PR><sdc:value>0.00000</sdc:value></sdc:i_PR><sdc:i_PR_INITIAL><sdc:value>0.00000</sdc:value></sdc:i_PR_INITIAL><sdc:i_RANKVAL><sdc:value>13.00000</sdc:value></sdc:i_RANKVAL><sdc:i_RANK_HOSTRANKVAL><sdc:value>13 U.S. Dollar</sdc:value></sdc:i_RANK_HOSTRANKVAL><sdc:i_RATE><sdc:value>1.00000</sdc:value></sdc:i_RATE><sdc:i_STATUS_MMC><sdc:value>N</sdc:value></sdc:i_STATUS_MMC><sdc:i_STGVAL><sdc:value>6.51700</sdc:value></sdc:i_STGVAL><sdc:i_TERMFEE><sdc:value>0.00000</sdc:value></sdc:i_TERMFEE><sdc:i_TFEEPCT><sdc:value>0.00000</sdc:value></sdc:i_TFEEPCT><sdc:i_TFEETOT><sdc:value>0.00000</sdc:value></sdc:i_TFEETOT><sdc:i_TTERMFEE><sdc:value>0.00000</sdc:value></sdc:i_TTERMFEE><sdc:i_VALLIA><sdc:value>0.00000</sdc:value></sdc:i_VALLIA><sdc:i_VALNOLIA><sdc:value>13.00000</sdc:value></sdc:i_VALNOLIA><sdc:i_VALUE><sdc:value>13.00000</sdc:value></sdc:i_VALUE><sdc:j_EQVALCF><sdc:value>0.00000</sdc:value></sdc:j_EQVALCF><sdc:j_EVCF><sdc:value>0.00000</sdc:value></sdc:j_EVCF><sdc:j_EVEBIT><sdc:value>0.00000</sdc:value></sdc:j_EVEBIT><sdc:j_EVNI><sdc:value>0.00000</sdc:value></sdc:j_EVNI><sdc:j_EVSALES><sdc:value>0.00000</sdc:value></sdc:j_EVSALES><sdc:j_MPRICEBOOK><sdc:value>0.00000</sdc:value></sdc:j_MPRICEBOOK><sdc:j_PHELD><sdc:value>0.00000</sdc:value></sdc:j_PHELD><sdc:j_PSOUGHT><sdc:value>100.00000</sdc:value></sdc:j_PSOUGHT><sdc:j_RANKVALCF><sdc:value>0.00000</sdc:value></sdc:j_RANKVALCF><sdc:j_RANKVALEB><sdc:value>0.00000</sdc:value></sdc:j_RANKVALEB><sdc:j_RANKVALNA><sdc:value>0.00000</sdc:value></sdc:j_RANKVALNA><sdc:j_RANKVALNI><sdc:value>0.00000</sdc:value></sdc:j_RANKVALNI><sdc:j_RANKVALSALES><sdc:value>17.33300</sdc:value></sdc:j_RANKVALSALES><sdc:j_VALEB><sdc:value>0.00000</sdc:value></sdc:j_VALEB><sdc:j_VALNI><sdc:value>0.00000</sdc:value></sdc:j_VALNI><sdc:j_VALSALES><sdc:value>17.33300</sdc:value></sdc:j_VALSALES><sdc:m_AMV><sdc:value>0.00000</sdc:value></sdc:m_AMV><sdc:m_CF3YGR><sdc:value>0.00000</sdc:value></sdc:m_CF3YGR><sdc:m_CF5YGR><sdc:value>0.00000</sdc:value></sdc:m_CF5YGR><sdc:m_DCR><sdc:value>0.00000</sdc:value></sdc:m_DCR><sdc:m_ENTVAL><sdc:value>0.00000</sdc:value></sdc:m_ENTVAL><sdc:m_EPS3YGR><sdc:value>0.00000</sdc:value></sdc:m_EPS3YGR><sdc:m_EPS5YGR><sdc:value>0.00000</sdc:value></sdc:m_EPS5YGR><sdc:m_LTD><sdc:value>0.00000</sdc:value></sdc:m_LTD><sdc:m_MV><sdc:value>0.00000</sdc:value></sdc:m_MV><sdc:m_NETASS><sdc:value>0.00000</sdc:value></sdc:m_NETASS><sdc:m_NETASS3YGR><sdc:value>0.00000</sdc:value></sdc:m_NETASS3YGR><sdc:m_NETASS5YGR><sdc:value>0.00000</sdc:value></sdc:m_NETASS5YGR><sdc:m_NI3YGR><sdc:value>0.00000</sdc:value></sdc:m_NI3YGR><sdc:m_NI5YGR><sdc:value>0.00000</sdc:value></sdc:m_NI5YGR><sdc:n_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value></sdc:n_SEQ><sdc:n_SYNOPSIS><sdc:value sdc:p="0">US - MDS Analytical</sdc:value><sdc:value sdc:p="1">Technologies, a unit of MDS</sdc:value><sdc:value sdc:p="2">Inc, acquired Blueshift</sdc:value><sdc:value sdc:p="3">Biotechnologies Inc, a</sdc:value><sdc:value sdc:p="4">manufacturer of semiconductor</sdc:value><sdc:value sdc:p="5">inspection instruments, for</sdc:value><sdc:value sdc:p="6">$13 mil.</sdc:value></sdc:n_SYNOPSIS><sdc:n_synopsis2><sdc:value>US - MDS Analytical Technologies, a unit of MDS Inc, acquired Blueshift Biotechnologies Inc, a manufacturer of semiconductor inspection instruments, for $13 mil.</sdc:value></sdc:n_synopsis2><sdc:n_synopsis3><sdc:value sdc:p="0">US - MDS Analytical Technologies, a unit of MDS Inc, acquired Blueshift Biotechnologies</sdc:value><sdc:value sdc:p="1">Inc, a manufacturer of semiconductor inspection instruments, for $13 mil.</sdc:value></sdc:n_synopsis3><sdc:n_synopsis4><sdc:value>US - MDS Analytical Technologies, a unit of MDS Inc, acquired Blueshift Biotechnologies Inc, a manufacturer of semiconductor inspection instruments, for $13 mil.</sdc:value></sdc:n_synopsis4><sdc:n_synopsis5><sdc:value sdc:p="0">US - MDS Analytical Technologies, a unit of MDS Inc, acquired Blueshift Biotechnologies Inc, a manufacturer of semiconductor inspection</sdc:value><sdc:value sdc:p="1">instruments, for $13 mil.</sdc:value></sdc:n_synopsis5><sdc:q_DESCR><sdc:value>Completed</sdc:value></sdc:q_DESCR><sdc:q_HOSTANETASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTANETASS><sdc:q_HOSTANILTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTANILTM><sdc:q_HOSTASALESLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTASALESLTM><sdc:q_HOSTATASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTATASS><sdc:q_HOSTBOOKVALUE><sdc:value>0.00000</sdc:value></sdc:q_HOSTBOOKVALUE><sdc:q_HOSTCASHFLOW><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW><sdc:q_HOSTCASHFLOW1><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW1><sdc:q_HOSTCASHFLOW2><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW2><sdc:q_HOSTCASHFLOW3><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW3><sdc:q_HOSTCASHFLOW4><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW4><sdc:q_HOSTCASHFLOW5><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW5><sdc:q_HOSTCOMMONEQUITY><sdc:value>0.00000</sdc:value></sdc:q_HOSTCOMMONEQUITY><sdc:q_HOSTEBITLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTEBITLTM><sdc:q_HOSTEPS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS1><sdc:q_HOSTEPS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS2><sdc:q_HOSTEPS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS3><sdc:q_HOSTEPS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS4><sdc:q_HOSTEPS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS5><sdc:q_HOSTEPSLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPSLTM><sdc:q_HOSTNETASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS><sdc:q_HOSTNETASS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS1><sdc:q_HOSTNETASS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS2><sdc:q_HOSTNETASS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS3><sdc:q_HOSTNETASS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS4><sdc:q_HOSTNETASS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS5><sdc:q_HOSTNI1><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI1><sdc:q_HOSTNI2><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI2><sdc:q_HOSTNI3><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI3><sdc:q_HOSTNI4><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI4><sdc:q_HOSTNI5><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI5><sdc:q_HOSTNILTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTNILTM><sdc:q_HOSTPTINC1><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC1><sdc:q_HOSTPTINC2><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC2><sdc:q_HOSTPTINC3><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC3><sdc:q_HOSTPTINC4><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC4><sdc:q_HOSTPTINC5><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC5><sdc:q_HOSTPTINCLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINCLTM><sdc:q_HOSTSALES1><sdc:value>0.75000</sdc:value></sdc:q_HOSTSALES1><sdc:q_HOSTSALES2><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES2><sdc:q_HOSTSALES3><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES3><sdc:q_HOSTSALES4><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES4><sdc:q_HOSTSALES5><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES5><sdc:q_HOSTSALESLTM><sdc:value>0.75000</sdc:value></sdc:q_HOSTSALESLTM><sdc:q_HOSTTASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS><sdc:q_HOSTTASS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS1><sdc:q_HOSTTASS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS2><sdc:q_HOSTTASS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS3><sdc:q_HOSTTASS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS4><sdc:q_HOSTTASS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS5><sdc:q_STATUS><sdc:value>Status:Completed</sdc:value></sdc:q_STATUS><sdc:r_CURR_CODE><sdc:value>US</sdc:value></sdc:r_CURR_CODE><sdc:r_PE><sdc:value>-999.00000</sdc:value></sdc:r_PE><sdc:r_PE_PRINT><sdc:value>np</sdc:value></sdc:r_PE_PRINT><sdc:r_PFTMARG><sdc:value>0.00000</sdc:value></sdc:r_PFTMARG><sdc:r_PRICEBOOK><sdc:value>-999.00000</sdc:value></sdc:r_PRICEBOOK><sdc:r_PRICEBOOK_PRINT><sdc:value>np</sdc:value></sdc:r_PRICEBOOK_PRINT><sdc:r_PTINC3YGR><sdc:value>0.00000</sdc:value></sdc:r_PTINC3YGR><sdc:r_PTINC5YGR><sdc:value>0.00000</sdc:value></sdc:r_PTINC5YGR><sdc:r_ROE><sdc:value>0.00000</sdc:value></sdc:r_ROE><sdc:r_SALES3YGR><sdc:value>0.00000</sdc:value></sdc:r_SALES3YGR><sdc:r_SALES5YGR><sdc:value>0.00000</sdc:value></sdc:r_SALES5YGR><sdc:r_SE><sdc:value>0.00000</sdc:value></sdc:r_SE><sdc:r_TASS3YGR><sdc:value>0.00000</sdc:value></sdc:r_TASS3YGR><sdc:r_TASS5YGR><sdc:value>0.00000</sdc:value></sdc:r_TASS5YGR><sdc:r_TTCFMULT><sdc:value>0.00000</sdc:value></sdc:r_TTCFMULT><sdc:r_TTEBITMULT><sdc:value>0.00000</sdc:value></sdc:r_TTEBITMULT><sdc:r_VALNA><sdc:value>0.00000</sdc:value></sdc:r_VALNA><sdc:sic_SIC><sdc:value sdc:p="0">3826:Laboratory analytical instruments</sdc:value><sdc:value sdc:p="1">3829:Measuring&amp;controlling devices</sdc:value></sdc:sic_SIC><sdc:upa_UPACIDGEN><sdc:value>103136002</sdc:value></sdc:upa_UPACIDGEN><sdc:upa1_EXCHANGE><sdc:value>Toronto</sdc:value></sdc:upa1_EXCHANGE><sdc:upa1_NATION><sdc:value>Canada</sdc:value></sdc:upa1_NATION><sdc:upa1_SICP><sdc:value>8071</sdc:value></sdc:upa1_SICP><sdc:upa1_STATE><sdc:value>Foreign</sdc:value></sdc:upa1_STATE><sdc:upa1_STATUS><sdc:value>Public</sdc:value></sdc:upa1_STATUS><sdc:upa1_TICKER><sdc:value>MDS</sdc:value></sdc:upa1_TICKER><sdc:upsic_SIC><sdc:value sdc:p="0">3826:Laboratory analytical instruments</sdc:value><sdc:value sdc:p="1">3829:Measuring&amp;controlling devices</sdc:value></sdc:upsic_SIC><sdc:upt_UPTCIDGEN><sdc:value>1025595001</sdc:value></sdc:upt_UPTCIDGEN><sdc:upt1_NATION><sdc:value>United States</sdc:value></sdc:upt1_NATION><sdc:upt1_SICP><sdc:value>3826</sdc:value></sdc:upt1_SICP><sdc:upt1_STATE><sdc:value>California</sdc:value></sdc:upt1_STATE><sdc:upt1_STATUS><sdc:value>Private</sdc:value></sdc:upt1_STATUS><sdc:x_RANK1_VALUE><sdc:value>13.00000</sdc:value></sdc:x_RANK1_VALUE><sdc:x_RANK_HOSTRANKVAL><sdc:value>13.00000</sdc:value></sdc:x_RANK_HOSTRANKVAL><sdc:x_RANK_RANKVAL><sdc:value>13.00000</sdc:value></sdc:x_RANK_RANKVAL><sdc:x_rank_rankstgval><sdc:value>6.51700</sdc:value></sdc:x_rank_rankstgval></sdc:deal><category>Deal Information</category><alacra:ip>Thomson Financial Mergers &amp; Acquisitions</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0001-26090509</link><guid isPermaLink="false">newstex/PRN-0001-26090509</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> WATERLOO, ON, Jun. ##, #### (Canada NewsWire Group delivered by Newstex) -- /CNW/ -- Shad Valley, an enrichment program targeted at youth grades ##, ##, and ## with a focus on science, technology, engineering and entrepreneurship, announced...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09015000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">11000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">11006000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016008</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04006000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04006005</newstex:cat><pubDate>6/19/2008 7:21:29 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18007000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18006000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19003000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002012</newstex:geo><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">Canada NewsWire Group</newstex:Publication><title>Shad Valley International announces new Chairperson, welcomes former Group President, Health Care of MDS Inc., John Morrison</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0001-26090509</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MDS INC</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MDS</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MDZ</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1776846</link><guid isPermaLink="false">ccbn/T1776846</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good morning, ladies and gentlemen, welcome to the MDS second quarter results conference call. I would like to turn the meeting over to Kim Lee, Director of Investor Relations. Please go ahead Ms. Lee. ...

</description><pubDate>6/5/2008 11:04:00 AM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">MDS Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q2 2008 MDS Inc. Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MDZ</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:30am ET</ccbn:time><title>Q2 2008 MDS Inc. Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1776846</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1776845</link><guid isPermaLink="false">ccbn/T1776845</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good morning, ladies and gentlemen. Welcome to the MDS first quarter results conference call. I would now like to turn the meeting over to Kim Lee, Director of Investor Relations. Please go ahead Ms. Lee. ...

</description><pubDate>3/6/2008 11:06:00 AM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">MDS Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q1 2008 MDS Inc. Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MDZ</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:30am ET</ccbn:time><title>Q1 2008 MDS Inc. Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1776845</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1746039</link><guid isPermaLink="false">ccbn/T1746039</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>... - MDS, Inc. -  Director - IR Good morning, everyone, and welcome. My name is Kim Lee, Director of Investor Relations for MDS. I would like to welcome  all of you today, both here in person and those of you joining us live via webcast. While this is MDS's ##th annual Investor Day, this is the first time that we are hosting this event here in New York City. Given that over ##% of our institutional shareholders are now based in the U.S., it only made sense. In considering venues, we decided to return to where we took our first step into the U.S. market, here at the New York Stock Exchange. Thank you all for joining us.As we look back over the last two years, there truly is a world of difference at MDS. Having completed the transformation of the Company, our key focus now is driving growth as a global life sciences company. Today, MDS is more global than ever and the growth opportunities we are pursuing are coming from the world's most rapidly growing markets. We are continuing to drive innovation...

</description><pubDate>2/28/2008 4:10:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">MDS Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">2008 Annual Investor Day Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MDZ</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:00am ET</ccbn:time><title>2008 Annual Investor Day Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1746039</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1450738</link><guid isPermaLink="false">ccbn/T1450738</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><pubDate>12/31/2007 5:21:07 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">MDS Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q4 2007 MDS Inc. Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MDZ</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:30am ET</ccbn:time><title>Q4 2007 MDS Inc. Earnings Conference Call Transcript</title><description>...Good morning, ladies and gentlemen. Welcome to the MDS fourth quarter results conference call. I would now like to turn the meeting over to Sharon Mathers, Vice President of Investor Relations and External Communications. Please go ahead, Ms. Mathers....

</description><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1450738</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item></channel></rss>